3
Announcements
Trials
Browse
Landscape
Status
Unknown
3
Completed
3
Recruiting
2
Active not recruiting
2
Terminated
1
Sponsor Class
OTHER
2
OTHER_GOV
1
Study Type
Observational
3
Sponsor
Cancer Type
Gastrointestinal
27
Thoracic
19
Breast
14
Head & Neck
13
Other hematologic neoplasm
12
Genitourinary
12
Gynecologic
9
Tumor-Agnostic
7
Lymphoid
7
Dermatologic
7
CNS
6
Sarcoma
5
Myeloid
5
Endocrine
3
Plasma cell
1
Other solid neoplasm
1
Conditions
Thyroid Carcinoma, Anaplastic
1
Thyroid Cancer, Papillary
1
Adrenocortical Carcinoma
1
Interventions
lutetium Lu 177 dotatate
6
Everolimus
6
lanreotide
5
anlotinib
5
Temozolomide
5
Injections
4
Dexmedetomidine
4
Cisplatin
4
surufatinib
3
Thyrotropin Alfa
3
Sodium Chloride
3
Saline Solution
3
Fluorodeoxyglucose F18
3
Blood Specimen Collection
3
177Lu-octreotide, DOTA(0)-Tyr(3)-
3
(177)Lu-DOTA-EB-TATE
3
sintilimab
2
penpulimab
2
cabozantinib
2
Surgical Procedures, Operative
2
Sorafenib
2
Rosiglitazone
2
Radiotherapy
2
Radiofrequency Ablation
2
Positron Emission Tomography Computed Tomography
2
Paclitaxel
2
Nivolumab
2
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
2
Metformin
2
Magnetic Resonance Spectroscopy
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Unknown
×
Blood Specimen Collection
×
Endocrine
×
Clear all
NCT05989555
2023-11-18
SCIMITAR
Radboud University Medical Center
Unknown
30 enrolled
NCT05660889
2022-12-21
AVS for ACC
Erasmus Medical Center
Unknown
25 enrolled
NCT01774279
2021-01-05
iNATT
Velindre NHS Trust
Unknown
350 enrolled